BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT06898957-completion@plaintrial.com
DTSTAMP:20261027T020725Z
DTSTART;VALUE=DATE:20310423
SUMMARY:Study of Tarlatamab in Combination With YL201 With or Without Anti-
 programmed Death Ligand 1 (PD-L1) in Participants With Extensive Stage (ES
 ) Small Cell Lung Cancer (SCLC) — estimated completion date
DESCRIPTION:Recruiting. Saved on your PlainTrial shortlist. Full trial reco
 rd: https://plaintrial.com/trial/NCT06898957
URL:https://plaintrial.com/trial/NCT06898957
END:VEVENT
END:VCALENDAR
